X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs TORRENT PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD TORRENT PHARMA ALEMBIC LTD/
TORRENT PHARMA
 
P/E (TTM) x 119.3 28.6 416.6% View Chart
P/BV x 4.4 5.4 81.4% View Chart
Dividend Yield % 0.3 1.0 25.3%  

Financials

 ALEMBIC LTD   TORRENT PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
TORRENT PHARMA
Mar-17
ALEMBIC LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs531,768 3.0%   
Low Rs291,186 2.5%   
Sales per share (Unadj.) Rs4.7346.1 1.4%  
Earnings per share (Unadj.) Rs8.855.2 15.9%  
Cash flow per share (Unadj.) Rs9.073.3 12.3%  
Dividends per share (Unadj.) Rs0.1514.00 1.1%  
Dividend yield (eoy) %0.40.9 38.5%  
Book value per share (Unadj.) Rs27.7257.1 10.8%  
Shares outstanding (eoy) m267.03169.22 157.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.74.3 203.9%   
Avg P/E ratio x4.726.8 17.5%  
P/CF ratio (eoy) x4.620.1 22.6%  
Price / Book Value ratio x1.55.7 25.8%  
Dividend payout %1.725.4 6.7%   
Avg Mkt Cap Rs m10,962249,887 4.4%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m2389,934 2.4%   
Avg. sales/employee Rs ThNM4,971.5-  
Avg. wages/employee Rs ThNM843.2-  
Avg. net profit/employee Rs ThNM792.4-  
INCOME DATA
Net Sales Rs m1,26058,569 2.2%  
Other income Rs m2642,233 11.8%   
Total revenues Rs m1,52460,802 2.5%   
Gross profit Rs m8313,773 0.6%  
Depreciation Rs m613,069 2.0%   
Interest Rs m02,056 0.0%   
Profit before tax Rs m28510,881 2.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m61,545 0.4%   
Profit after tax Rs m2,3439,336 25.1%  
Gross profit margin %6.623.5 27.9%  
Effective tax rate %2.114.2 15.1%   
Net profit margin %185.915.9 1,166.2%  
BALANCE SHEET DATA
Current assets Rs m1,68953,841 3.1%   
Current liabilities Rs m48631,612 1.5%   
Net working cap to sales %95.438.0 251.4%  
Current ratio x3.51.7 203.9%  
Inventory Days Days21797 223.2%  
Debtors Days Days8184 96.7%  
Net fixed assets Rs m1,62442,079 3.9%   
Share capital Rs m534846 63.1%   
"Free" reserves Rs m5,96042,655 14.0%   
Net worth Rs m7,40443,501 17.0%   
Long term debt Rs m10422,408 0.5%   
Total assets Rs m8,010101,250 7.9%  
Interest coverage x950.76.3 15,106.0%   
Debt to equity ratio x00.5 2.7%  
Sales to assets ratio x0.20.6 27.2%   
Return on assets %29.311.3 260.0%  
Return on equity %31.621.5 147.4%  
Return on capital %31.319.6 159.4%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Exports (fob) Rs m37NA-   
Imports (cif) Rs m364NA-   
Fx inflow Rs m3720,066 0.2%   
Fx outflow Rs m3655,304 6.9%   
Net fx Rs m-32814,762 -2.2%   
CASH FLOW
From Operations Rs m34610,127 3.4%  
From Investments Rs m-48-7,869 0.6%  
From Financial Activity Rs m-301-1,918 15.7%  
Net Cashflow Rs m-3212 -1.4%  

Share Holding

Indian Promoters % 64.0 71.5 89.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 7.0 2.8%  
FIIs % 9.7 12.6 77.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 8.8 296.6%  
Shareholders   54,701 26,511 206.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   MERCK LTD  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 16, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS